Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
272 questions in 49 reviews · Heart
current versionsNo studies 272 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Lidocaine vs propafenone Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs placebo or no intervention Overall survival at 30 days after myocardial infarction · patients with acute myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse event · participants with CHD after PCI Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention (2015) · Cochrane | no estimate extracted | NR | No studies |
Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease (2013) · Cochrane | no estimate extracted | NR | No studies |
Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease (2013) · Cochrane | no estimate extracted | NR | No studies |
Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease (2013) · Cochrane | no estimate extracted | NR | No studies |
Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease (2013) · Cochrane | no estimate extracted | NR | No studies |